A pre-print of the results of a study of 386 coronavirus patients in a US government hospital for military veterans found more deaths among those treated with hydroxychloroquine than those treated with standard care. These findings highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of this drug, say the authors of the study.
Link to article: https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v2
In a joint statement on April 8, the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society cast doubts as to the safety of hydroxychloroquine and azithromycin for potential prophylaxis or treatment for COVID-19; both drugs are listed as definite causes of torsade de pointes” and increase in the risk of other arrhythmias and sudden death”, the statement says. In addition “seriously ill patients often have comorbidities that can increase risk of serious arrhythmias,” including hypokalemia, hypomagnesemia, fever, and systemic inflammation, the groups said.
Link to PDF:
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment